▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2799 by analyst upside · 2026-11-13
FTRE
Fortrea Holdings Inc.
Healthcare · Market Cap $2B · P/E 0x
ANALYST PRICE TARGET
+17.8%
implied upside to consensus target
Current Price $20.06
Consensus Target $23.62
Bull Target $29.0
Bear Target $13.5
Analysts Covering 12
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
6
Hold
3
Sell
2
52-Week Low $8.55
52-Week High $26.16
YTD Return +19.3%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) N/A
Forward P/E 18.0x
EPS (TTM) $-0.73
PEG Ratio 0.34
Dividend Yield N/A
Revenue (TTM) $2.7B
Profit Margin -2.6%
52-WEEK RANGE
52-Week Low $8.55
52-Week High $26.16
Current Price $20.06
Bear Target $13.5
Bull Target $29.0
● Now $20.06 ● Target $23.62
TRADING DATA
Avg Volume 1.7M
YTD Return +19.3%
Analyst Count 12
Consensus Buy
Upside to Target +17.8%
Last Updated 2026-11-13

ANALYST SUMMARY

Fortrea Holdings Inc. (FTRE) is currently trading at $20.06 with a Wall Street consensus price target of $23.62, implying potential upside of 17.8% over the next 12 months. 12 analysts currently cover FTRE, with a consensus rating of Buy - 58% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $29.0, while the most cautious has a target of $13.5.

FTRE operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 19.3% year-to-date and is currently trading near the upper end of its 52-week range of $8.55 – $26.16.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for FTRE, with each firm's 90-day track record across all stocks we track. See full firm rankings →

TD Cowen - Reiterated
Buy → Buy 2026-11-02 Building track record
Citigroup - Reiterated
Buy → Buy 2026-10-30 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-10-30 Building track record
Barclays - Reiterated
Overweight → Overweight 2026-10-30 Building track record
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-10-30 Building track record
UBS - Reiterated
Neutral → Neutral 2026-10-20 33% win rate (6 calls)
Deutsche Bank ↑ Upgrade
Hold → Buy 2026-10-15 Building track record
Barclays ↑ Upgrade
Equal-Weight → Overweight 2026-10-06 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
42
out of 100
Coverage depth
20/30
Consensus clarity
15/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →